ENGN News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-11 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 8.01,9.01. |
| 2026-07-17 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-07-16 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2026-06-18 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K/A | enGene Therapeutics Inc. filed Form 8-K/A covering items 2.05,5.02. |
| 2026-06-15 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,2.05,5.02,7.01,8.01,9.01. |
| 2026-06-10 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.07,9.01. |
| 2026-05-07 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,8.01,9.01. |
| 2026-04-09 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.03,7.01,9.01. |
| 2026-03-09 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-03-09 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,1.02,9.01. |
| 2026-01-21 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-01-21 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,2.03,3.02,9.01. |
| 2025-12-22 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-11-14 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,7.01,9.01. |
| 2025-11-12 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2025-10-02 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K/A | enGene Therapeutics Inc. filed Form 8-K/A covering items 5.02. |
| 2025-10-02 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02. |
| 2025-09-30 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-09-11 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-09-03 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2025-07-08 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2025-06-12 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-06-10 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,5.07,9.01. |
| 2025-06-09 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,2.03,9.01. |
| 2025-06-04 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2025-03-10 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-12-20 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,9.01. |
| 2024-12-19 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,2.02,2.03,9.01. |
| 2024-10-25 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01. |
| 2024-10-21 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,8.01,9.01. |
| 2024-09-26 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2024-09-10 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-09-05 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 7.01,9.01. |
| 2024-07-24 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,8.01,9.01. |
| 2024-06-14 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,7.01. |
| 2024-05-15 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,5.07,9.01. |
| 2024-03-11 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2024-02-14 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,3.02,5.02,7.01,9.01. |
| 2024-01-29 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 2.02,9.01. |
| 2023-12-28 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,2.03,3.02,9.01. |
| 2023-12-21 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2023-12-13 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,9.01. |
| 2023-11-29 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,7.01,9.01. |
| 2023-11-09 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 5.02,9.01. |
| 2023-10-31 | Current report | SEC filing | enGene Therapeutics Inc. filed Form 8-K | enGene Therapeutics Inc. filed Form 8-K covering items 1.01,2.01,3.02,3.03,5.01,5.02,5.03,5.05,5.06,9.01. |